Neuronostics

Remote EEG Reading and Reporting to accelerate your research. Bottlenecks in research happen all the time, but they don't have to. Enquire today.

Neuronostics drives innovation in digital biomarkers for neurological conditions.

Recent clinical work has implicated network structure as critically important in the initiation of seizures in people with idiopathic generalized epilepsies.

In July 2020, Neuronostics surveyed the epilepsy community to gather input for an app called ConnectEP.

We are pleased to be able to share the latest work from our team: ‘Estimating the likelihood of epilepsy from clinically non-contributory electroencephalograms using computational analysis: A retrospective, multisite case–control study’. This work has just appeared in Epilepsia, a leading, authoritative journal for innovative clinical and basic science research for all aspects of epilepsy and […]

Neuronostics aims to reduce diagnostic uncertainty for suspected epilepsy by developing tools to improve accuracy and speed.

Neuronostics won the *best new startup* award at the Medlink South West Healthcare Innovation awards in February 2020.

A 2023 pitch video introduces Neuronostics and its BioEP technology.

Dr. Leandro Junges presented at the Cornwall Partnership NHS Foundation Trust’s showcase event, supported by Neuronostics’ academic partners.

The page provides access to Neuronostics’ latest news, blogs, and press releases.

Neuronostics partnered with the Universities of Nottingham and Birmingham for an MRC-funded PhD studentship on epilepsy as a dynamic disease.

Neuronostics sought full-stack developers in 2020 to expand its BioEP platform and ConnectEP app with AI/ML capabilities.

The Neuronostics Board of Directors includes co-founders, investor directors, and non-executive directors.

The Neuronostics team includes experts in mathematical modeling, clinical practice, research, technology, MedTech, and commercialization.

Neuronostics develops digital biomarkers to improve neurological condition diagnosis, treatment, and monitoring in neurology centers worldwide.

Answers to common questions about BioEP: what it is, how it analyses routine EEG to support epilepsy diagnosis, and how hospitals can use it.

Neuronostics uses mathematical modeling to redefine diagnosis, treatment, and monitoring of neurological conditions.

The page explains how Neuronostics uses cookies and allows users to manage their settings.

The page outlines Neuronostics’ data collection, usage, and protection policies under data protection law.